Aetos Pharma Private Limited is one of the top suppliers of Anti-HIV drugs that also manufactures and exports the products to many countries in Latin America, Africa, and Asia, and many other countries.
Through our team of professionals, we have created products that are cost-effective for the patient and offer the highest quality standards.
Our expert team ensures the timely delivery of the products to our clients and buyers. Through our commitment to giving the best to our buyers, we have ensured the best range of Anti-HIV products.
We offer products in ready stock and also provide third-party contract manufacturing to our clients and buyers who want the products in their brand name.
Aetos Pharma Private Limited is an HIV drug manufacturer based in Ahmedabad, India. We offer HIV drugs that are used to treat HIV and to improve the immune system performance which helps prolongs the life span of the patients.
HIV is a sexually transmitted disease however it can also transfer through coming in contact with breast milk, and body fluids.
The chances of the infection increase when there is an exchange of body fluids and there is a cut on the skin internally or externally. However, precaution is the best defense against HIV.
We manufacture affordable and best-quality HIV drugs so we have various satisfied clients overseas who import container-load medicines from us to distribute through their efficient sales channels.
Aetos Pharma Private Limited is one of the top Manufacturer and exporter of HIV drugs. All our manufacturing facilities are WHO-GMP accredited. We provide contract manufacturing and third-party manufacturing for our overseas clients.
What are HIV drugs and how do they work?
HIV drugs help you to reduce your viral load. These drugs are not the cure for HIV. HIV drugs help you to reduce your viral load so that you reduce the chance of passing the virus to your partner. This drug improves the function of your immune system.
Your Doctor will instruct you on the does and the regime suitable for you. If you skip the dose you may be at risk of developing the drug-resistant strain which might make the treatment difficult. Do not take another drug without informing your doctor as there is the risk of contraindication or adverse reaction.
The seven HIV drug classes are:
1. Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
The class of drugs known as non-nucleoside reverse transcriptase inhibitors (NNRTIs) work by binding to and obstructing the action of HIV reverse transcriptase, an enzyme used by the virus to convert its RNA into DNA through reverse transcription. This mechanism of blocking reverse transcription ultimately thwarts HIV from reproducing, thus playing an important role in HIV treatment.
Examples of NNRTIs
- Delavirdine (DLV),
- Doravirine (DOR),
- Efavirenz (EFV),
- Etravirine (ETR),
- Nevirapine (NVP)
- Rilpivirine (RPV
2. Nucleoside reverse transcriptase inhibitors (NRTIs)
NRTIs, also known as nucleoside/nucleotide reverse transcriptase inhibitors, was the first antiretroviral drugs to gain FDA approval. These drugs function as prodrugs and necessitate being transported into the host cell where they are subsequently phosphorylated to become active. Upon entry into the host cell, the drug is activated through cellular kinases.
Examples of NRTIs
- Zidovudine
- Abacavir sulfate
- Emtricitabine
- Tenofovir disoproxil fumarate
- Lamivudine and zidovudine
- Abacavir and lamivudine
- Abacavir, zidovudine, and lamivudine
- Tenofovir disoproxil fumarate and emtricitabine
3. Protease inhibitors (PIs)
Antiretroviral protease inhibitors are effective in combating HIV by binding to the catalytic site of the HIV protease, which in turn inhibits the cleavage of viral polyprotein precursors into mature and functional proteins that are crucial for viral replication. This interference impedes the virus from reproducing and spreading further.
Examples of PIs
- Saquinavir,
- Indinavir,
- Ritonavir,
- Nelfinavir,
- Amprenavir,
- Fosamprenavir,
- Lopinavir,
- Atazanavir,
- Tipranavir,
- Darunavir
4. Fusion inhibitors.
Fusion inhibitors work by disrupting the entry of HIV into target cells, with maraviroc binding to the chemokine receptor (CCR) type 5 receptor present on CD4 Th cells. On the other hand, integrase inhibitors, such as raltegravir, function by preventing the viral integrase enzyme from inserting the DNA copy of the viral genome into the host-cell chromosome. This mechanism of action effectively impedes the replication and propagation of the virus.
Examples of Fusion inhibitors
- Atazanavir
- Darunavir
- Fosamprenavir
- Ritonavir
5.CCR5 antagonists.
CCR5 receptor antagonists are a group of small molecules that act by blocking the CCR5 receptor. The CCR5 receptor, a chemokine receptor with a C-C motif, plays a critical role in the mechanism by which HIV, the causative agent of AIDS, enters into host cells. By inhibiting the function of the CCR5 receptor, CCR5 receptor antagonists can impede the entry of the virus into the cells, which is an essential step in the replication and spread of HIV.
Examples of CCR5 antagonists
- Maraviroc
- Aplaviroc
- Vicriviroc
6.Integrase strand transfer inhibitors (INSTIs)
This is oral agents available for the treatment.
Example of INSTIs
- Bictegravir (BIC)
- Dolutegravir (DTG)
- Elvitegravir (EVG)
- Raltegravir (RAL)
7. Post-attachment inhibitors.
Post-attachment inhibitors refer to a group of medications that attach to the CD4 receptor located on a host CD4 cell. As a result, this action prevents the attachment of HIV to the CCR5 and CXCR4 coreceptors, ultimately impeding its entry into the cell.
Example of Post-attachment Inhibitors.
- Ibalizumab
HIV Medicines Manufacturer and Exporter:
Aetos Pharma Private Limited is the leading manufacturer, and exporter of anti-HIV medicines, offering anti-HIV medicines of the highest standards at affordable rates. We have a WHO-GMP-certified manufacturing facility. All our medicines are supplied under controlled temperature conditions which ensures that medicines reach in the best quality conditions to our overseas clients and buyers.
Aetos Pharma Private Limited is a leading WHO-GMP EU-GMP Pharmaceuticals Manufacturer exports products to the following continents
Angola | Benin | Botswana | Burkina Faso | Burundi | Cameroon | Cape Verde | Central African Republic | Chad (Tchad) | Comoros | Republic of the Congo | Democratic Republic of the Congo | Côte d’Ivoire (Ivory Coast) | Djibouti | Equatorial Guinea | Egypt (Misr) | Eritrea | Ethiopia (Abyssinia) | Gabon | The Gambia | Ghana | Guinea | Guinea-Bissau | Kenya | Lesotho | Liberia | Libya | Madagascar | Malawi | Algeria | Mali | Mauritania | Mauritius | Morocco (Al Maghrib) | Mozambique | Namibia | Niger | Nigeria | Rwanda | São Tomé and Príncipe | Senegal | Seychelles | Sierra Leone | Somalia | South Africa | South Sudan | Sudan | Swaziland (Eswatini) | Tanzania | Togo | Tunisia | Uganda | Western Sahara | Zambia | Zimbabwe
Afghanistan | Armenia | Azerbaijan | Bahrain | Bangladesh | Bhutan | Brunei | Cambodia (Kampuchea) | Georgia | India | Indonesia | Iran | Iraq | Japan | Jordan (Al Urdun) | Kazakhstan | Kuwait | Kyrgyzstan | Laos | Lebanon (Lubnan) | Malaysia | Maldives | Mongolia | Myanmar (Burma) | Nepal | North Korea | Oman | Philippines | Qatar | Russia | Saudi Arabia | Singapore | South Korea | Sri Lanka | Syria | Tajikistan | Thailand | Turkey | Turkmenistan| Taiwan | United Arab Emirates | Uzbekistan | Vietnam | Yemen
Albania | Andorra | Austria | Belarus | Belgium | Bosnia and Herzegovina | Bulgaria | Croatia | Cyprus | Czech Republic | Denmark | Estonia | Finland | Georgia | Germany | Greece | Hungary | Iceland | Republic of Ireland | Italy | Kosovo | Latvia | Liechtenstein | Lithuania | Luxembourg | North Macedonia | Malta | Moldova | Monaco | Montenegro | Netherlands | Norway | Poland | Portugal | Romania | San Marino | Serbia | Slovakia | Slovenia | France | Spain | Sweden | Switzerland | Ukraine | United Kingdom
Canada | United States of America | Navassa Island | Puerto Rico | US Virgin Islands | Guam | American Samoa
Brazil | Argentina | Bolivia | Chile | Colombia | Ecuador | Falkland Islands | French Guiana | Guyana | Paraguay | Peru | South Georgia and the South Sandwich Islands | Suriname | Uruguay | Venezuela | Belize | Costa Rica | El Salvador | Guatemala | Honduras | Nicaragua | Panama | Haiti | Antigua and Barbuda | Bahamas | Barbados | Cuba | Dominica | Grenada | Jamaica | Saint Lucia | Saint Kitts and Nevis | Saint Vincent and the Grenadines | Trinidad and Tobago
Australia | Fiji | New Zealand | Federated States of Micronesia | Kiribati | Marshall Islands | Nauru | Palau | Papua New Guinea | Samoa | Solomon Islands | Tonga | Tuvalu | Vanuatu